1.24
price up icon2.48%   0.03
after-market Handel nachbörslich: 1.22 -0.02 -1.61%
loading
Schlusskurs vom Vortag:
$1.21
Offen:
$1.24
24-Stunden-Volumen:
567.55K
Relative Volume:
0.56
Marktkapitalisierung:
$116.91M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.31M
KGV:
-4.6881
EPS:
-0.2645
Netto-Cashflow:
$-21.07M
1W Leistung:
+9.73%
1M Leistung:
+79.68%
6M Leistung:
+40.91%
1J Leistung:
+21.57%
1-Tages-Spanne:
Value
$1.19
$1.25
1-Wochen-Bereich:
Value
$1.14
$1.35
52-Wochen-Spanne:
Value
$0.3258
$1.53

Oncolytics Biotech Inc Stock (ONCY) Company Profile

Name
Firmenname
Oncolytics Biotech Inc
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
28
Name
Twitter
@oncolytics
Name
Nächster Verdiensttermin
2025-05-02
Name
Neueste SEC-Einreichungen
Name
ONCY's Discussions on Twitter

Vergleichen Sie ONCY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
ONCY
Oncolytics Biotech Inc
1.24 109.16M 0 -20.31M -21.07M -0.2645
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Oncolytics Biotech Inc Stock (ONCY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2022-10-06 Eingeleitet Maxim Group Buy
2021-02-17 Eingeleitet H.C. Wainwright Buy

Oncolytics Biotech Inc Aktie (ONCY) Neueste Nachrichten

pulisher
Jul 22, 2025

What drives Oncolytics Biotech Inc. stock priceTriple returns potential - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Pancreas Cancer Becoming Top Focus for Biotech Co.? - streetwisereports.com

Jul 22, 2025
pulisher
Jul 22, 2025

Oncolytics Biotech Regains Compliance With Nasdaq's Minimum Bid Price Rule - 富途牛牛

Jul 22, 2025
pulisher
Jul 22, 2025

Oncolytics Biotech Regains Nasdaq Compliance as of July 22, 2025 - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Oncolytics Biotech® Regains Compliance with Nasdaq Trading Rules - The Globe and Mail

Jul 22, 2025
pulisher
Jul 22, 2025

Oncolytics Biotech regains compliance with Nasdaq listing requirements - Investing.com

Jul 22, 2025
pulisher
Jul 22, 2025

Oncolytics regains Nasdaq compliance - TipRanks

Jul 22, 2025
pulisher
Jul 22, 2025

Oncolytics Biotech Secures Nasdaq Future: Stock Maintains $1 Minimum for 10 Straight Days - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Oncolytics Biotech Inc. stockTremendous growth potential - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is Oncolytics Biotech Inc. a good long term investmentHigh-yield portfolio picks - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

Oncolytics Biotech Inc. Stock Analysis and ForecastExceptional profit potential - Autocar Professional

Jul 21, 2025
pulisher
Jul 21, 2025

How To Trade (ONC) (ONC:CA) - news.stocktradersdaily.com

Jul 21, 2025
pulisher
Jul 19, 2025

Oncolytics names Jared Kelly as CEO - MSN

Jul 19, 2025
pulisher
Jul 17, 2025

Oncolytics Biotech (ONCY) up more than 100% since Jun 23 - AInvest

Jul 17, 2025
pulisher
Jul 16, 2025

What makes Oncolytics Biotech Inc. stock price move sharplyAnalyst Grade Signals - beatles.ru

Jul 16, 2025
pulisher
Jul 16, 2025

Cancer Pipeline Milestones Coming Fast as Regulators Revisit Research Priorities - Cantech Letter

Jul 16, 2025
pulisher
Jul 16, 2025

Emerging Oncology Breakthroughs Signal Opportunity Despite Research Funding Crunch - Baystreet.ca

Jul 16, 2025
pulisher
Jul 16, 2025

Stocks In Play: Oncolytics Biotech Inc By Baystreet.ca - Investing.com Canada

Jul 16, 2025
pulisher
Jul 16, 2025

Stocks in play: Oncolytics Biotech Inc - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

Oncolytics Biotech Inc - Baystreet.ca

Jul 16, 2025
pulisher
Jul 16, 2025

Stocks In Play: Oncolytics Biotech Inc - Barchart.com

Jul 16, 2025
pulisher
Jul 16, 2025

Oncolytics Biotech Unveils Promising Data on Pelareorep’s Efficacy Across Tumor Types - TipRanks

Jul 16, 2025
pulisher
Jul 16, 2025

Oncolytics Biotech reports positive biomarker data for pelareorep By Investing.com - Investing.com South Africa

Jul 16, 2025
pulisher
Jul 16, 2025

Oncolytics Biotech® Presents Aggregated Translational Data Providing Evidence of Pelareorep's Effectiveness Across Multiple Tumor Types - Barchart.com

Jul 16, 2025
pulisher
Jul 15, 2025

(ONC) Trading Strategy and Analysis (ONC:CA) - news.stocktradersdaily.com

Jul 15, 2025
pulisher
Jul 13, 2025

How the (ONC) price action is used to our Advantage (ONC:CA) - news.stocktradersdaily.com

Jul 13, 2025
pulisher
Jul 11, 2025

Oncolytics Biotech Highlights Promising Pelareorep Data in Cancer Treatment - TipRanks

Jul 11, 2025
pulisher
Jul 11, 2025

Oncolytics Biotech stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com Canada

Jul 11, 2025
pulisher
Jul 10, 2025

Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - Cantech Letter

Jul 10, 2025
pulisher
Jul 10, 2025

Next-Gen Cancer Treatments Gain Steam Amid Oncology Industry Shakeups - Baystreet.ca

Jul 10, 2025
pulisher
Jul 10, 2025

USA News Group: Cancer Innovation Accelerates as Funding Cuts Loom and Biotechs Step Up - FinanzNachrichten.de

Jul 10, 2025
pulisher
Jul 10, 2025

Oncolytics Biotech to Host Webinar on Pelareorep’s Potential in Cancer Treatment - TipRanks

Jul 10, 2025
pulisher
Jul 10, 2025

Oncolytics Biotech® to Host Key Opinion Leader Discussion Focusing on Pancreatic and Gastrointestinal Cancers - StreetInsider

Jul 10, 2025
pulisher
Jul 10, 2025

(ONC) Investment Analysis (ONC:CA) - news.stocktradersdaily.com

Jul 10, 2025
pulisher
Jul 09, 2025

Pelareorep: A Breakthrough in Oncolytics Biotech's Fight Against Pancreatic and Breast Cancers – A High-Conviction Buy at Current Levels? - AInvest

Jul 09, 2025
pulisher
Jul 08, 2025

Oncolytics Biotech reports improved survival rates in cancer studies By Investing.com - Investing.com South Africa

Jul 08, 2025
pulisher
Jul 08, 2025

Amid NCI Budget Fears, Emerging Oncology Stocks Gain Attention - Cantech Letter

Jul 08, 2025

Finanzdaten der Oncolytics Biotech Inc-Aktie (ONCY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):